TGTX logo

TG Therapeutics, Inc. (TGTX) EBIT

Annual EBIT:

$49.62M+$23.95M(+93.25%)
December 31, 2024

Summary

  • As of today, TGTX annual earnings before interest & taxes is $49.62 million, with the most recent change of +$23.95 million (+93.25%) on December 31, 2024.
  • During the last 3 years, TGTX annual EBIT has risen by +$392.08 million (+114.49%).
  • TGTX annual EBIT is now at all-time high.

Performance

TGTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

Quarterly EBIT:

$37.64M+$25.41M(+207.86%)
June 30, 2025

Summary

  • As of today, TGTX quarterly earnings before interest & taxes is $37.64 million, with the most recent change of +$25.41 million (+207.86%) on June 30, 2025.
  • Over the past year, TGTX quarterly EBIT has increased by +$27.11 million (+257.48%).
  • TGTX quarterly EBIT is now -68.01% below its all-time high of $117.64 million, reached on September 30, 2023.

Performance

TGTX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

TTM EBIT:

$97.47M+$27.11M(+38.52%)
June 30, 2025

Summary

  • As of today, TGTX TTM earnings before interest & taxes is $97.47 million, with the most recent change of +$27.11 million (+38.52%) on June 30, 2025.
  • Over the past year, TGTX TTM EBIT has dropped by -$10.71 million (-9.90%).
  • TGTX TTM EBIT is now -9.90% below its all-time high of $108.19 million, reached on June 30, 2024.

Performance

TGTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

TGTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+93.3%+257.5%-9.9%
3Y3 Years+114.5%+200.4%+134.7%
5Y5 Years+129.6%+174.3%+143.6%

TGTX EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+114.5%-68.0%+149.8%-9.9%+142.3%
5Y5-Yearat high+114.5%-68.0%+140.8%-9.9%+128.5%
All-TimeAll-Timeat high+114.5%-68.0%+140.8%-9.9%+128.5%

TGTX EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$37.64M(+207.9%)
$97.47M(+38.5%)
Mar 2025
-
$12.22M(-62.4%)
$70.37M(+41.4%)
Dec 2024
$49.62M(+93.3%)
$32.51M(+115.3%)
$49.75M(+781.7%)
Sep 2024
-
$15.10M(+43.4%)
$5.64M(-94.8%)
Jun 2024
-
$10.53M(+225.5%)
$108.19M(+101.6%)
Mar 2024
-
-$8.39M(+27.6%)
$53.67M(+109.0%)
Dec 2023
$25.68M(+112.0%)
-$11.60M(-109.9%)
$25.68M(+167.0%)
Sep 2023
-
$117.64M(+367.5%)
-$38.34M(+79.8%)
Jun 2023
-
-$43.98M(-20.9%)
-$190.15M(-3.5%)
Mar 2023
-
-$36.39M(+51.9%)
-$183.66M(+14.0%)
Dec 2022
-$213.62M(+37.6%)
-$75.61M(-121.3%)
-$213.62M(+7.2%)
Sep 2022
-
-$34.17M(+8.9%)
-$230.27M(+18.0%)
Jun 2022
-
-$37.49M(+43.5%)
-$280.70M(+12.3%)
Mar 2022
-
-$66.35M(+28.1%)
-$320.08M(+6.5%)
Dec 2021
-$342.46M(-25.4%)
-$92.26M(-9.1%)
-$342.46M(-1.6%)
Sep 2021
-
-$84.60M(-10.1%)
-$337.13M(+0.3%)
Jun 2021
-
-$76.87M(+13.4%)
-$338.08M(-8.4%)
Mar 2021
-
-$88.73M(-2.1%)
-$311.87M(-14.2%)
Dec 2020
-$273.05M(-62.9%)
-$86.93M(-1.6%)
-$273.05M(-22.0%)
Sep 2020
-
-$85.55M(-68.9%)
-$223.80M(-12.7%)
Jun 2020
-
-$50.66M(-1.5%)
-$198.64M(-8.5%)
Mar 2020
-
-$49.91M(-32.5%)
-$183.12M(-9.3%)
Dec 2019
-$167.58M(+2.9%)
-$37.67M(+37.6%)
-$167.58M(+8.7%)
Sep 2019
-
-$60.39M(-71.9%)
-$183.55M(-17.0%)
Jun 2019
-
-$35.14M(-2.2%)
-$156.89M(+5.3%)
Mar 2019
-
-$34.38M(+35.9%)
-$165.67M(+4.2%)
Dec 2018
-$172.60M(-46.7%)
-$53.64M(-59.0%)
-$172.87M(-15.9%)
Sep 2018
-
-$33.73M(+23.2%)
-$149.18M(-1.5%)
Jun 2018
-
-$43.92M(-5.6%)
-$147.03M(-11.8%)
Mar 2018
-
-$41.58M(-38.8%)
-$131.54M(-11.8%)
Dec 2017
-$117.63M(-49.0%)
-$29.95M(+5.2%)
-$117.63M(-5.3%)
Sep 2017
-
-$31.59M(-11.1%)
-$111.70M(-6.3%)
Jun 2017
-
-$28.43M(-2.7%)
-$105.04M(-13.4%)
Mar 2017
-
-$27.67M(-15.1%)
-$92.64M(-17.3%)
Dec 2016
-$78.97M(-25.0%)
-$24.03M(+3.6%)
-$78.97M(-7.4%)
Sep 2016
-
-$24.93M(-55.6%)
-$73.52M(-18.6%)
Jun 2016
-
-$16.02M(-14.5%)
-$62.00M(+1.3%)
Mar 2016
-
-$13.99M(+24.7%)
-$62.83M(+0.6%)
Dec 2015
-$63.18M(-13.4%)
-$18.57M(-38.5%)
-$63.18M(+1.3%)
Sep 2015
-
-$13.41M(+20.5%)
-$64.04M(+5.6%)
Jun 2015
-
-$16.86M(-17.5%)
-$67.85M(-8.1%)
Mar 2015
-
-$14.34M(+26.2%)
-$62.74M(-12.6%)
Dec 2014
-$55.72M(-185.4%)
-$19.43M(-12.9%)
-$55.72M(-33.6%)
Sep 2014
-
-$17.22M(-46.5%)
-$41.71M(-44.8%)
Jun 2014
-
-$11.75M(-60.5%)
-$28.81M(-23.1%)
Mar 2014
-
-$7.32M(-35.0%)
-$23.40M(-19.9%)
Dec 2013
-$19.53M(+21.7%)
-$5.42M(-25.7%)
-$19.53M(-14.5%)
Sep 2013
-
-$4.32M(+32.0%)
-$17.05M(-12.1%)
Jun 2013
-
-$6.34M(-84.3%)
-$15.21M(-35.7%)
Mar 2013
-
-$3.44M(-17.0%)
-$11.21M(+55.1%)
Dec 2012
-$24.95M(-2728.5%)
-$2.94M(-18.6%)
-$24.95M(-10.6%)
Sep 2012
-
-$2.48M(-5.8%)
-$22.56M(-12.2%)
Jun 2012
-
-$2.35M(+86.3%)
-$20.11M(-11.3%)
Mar 2012
-
-$17.18M(-2995.4%)
-$18.06M(+5.7%)
Dec 2011
-$882.00K(+56.3%)
-$554.90K(-1743.5%)
-$19.15M(+12.2%)
Sep 2011
-
-$30.10K(+89.9%)
-$21.81M(-2.0%)
Jun 2011
-
-$297.00K(+98.4%)
-$21.39M(+1.1%)
Mar 2011
-
-$18.27M(-468.6%)
-$21.61M(-457.6%)
Dec 2010
-$2.02M
-$3.21M(-922.1%)
-$3.88M(-285.7%)
DateAnnualQuarterlyTTM
Sep 2010
-
$390.80K(+174.4%)
-$1.00M(+43.9%)
Jun 2010
-
-$525.10K(+0.8%)
-$1.79M(-2.7%)
Mar 2010
-
-$529.40K(-55.1%)
-$1.74M(+1.6%)
Dec 2009
-$1.77M(+59.9%)
-$341.30K(+13.7%)
-$1.77M(-28.6%)
Sep 2009
-
-$395.60K(+17.1%)
-$1.38M(+41.8%)
Jun 2009
-
-$477.30K(+14.4%)
-$2.37M(+29.5%)
Mar 2009
-
-$557.30K(-1165.6%)
-$3.36M(+23.9%)
Dec 2008
-$4.41M(+63.7%)
$52.30K(+103.8%)
-$4.41M(+30.9%)
Sep 2008
-
-$1.38M(+5.7%)
-$6.38M(+17.2%)
Jun 2008
-
-$1.47M(+9.1%)
-$7.71M(+31.0%)
Mar 2008
-
-$1.61M(+15.9%)
-$11.16M(+8.1%)
Dec 2007
-$12.14M(-21.4%)
-$1.92M(+29.1%)
-$12.14M(+9.4%)
Sep 2007
-
-$2.71M(+45.0%)
-$13.41M(-5.9%)
Jun 2007
-
-$4.92M(-89.8%)
-$12.66M(-25.4%)
Mar 2007
-
-$2.59M(+18.4%)
-$10.10M(-1.0%)
Dec 2006
-$10.00M(+48.3%)
-$3.18M(-61.8%)
-$10.00M(+53.2%)
Sep 2006
-
-$1.97M(+16.6%)
-$21.35M(-0.5%)
Jun 2006
-
-$2.36M(+5.6%)
-$21.24M(-4.2%)
Mar 2006
-
-$2.50M(+82.8%)
-$20.40M(-5.4%)
Dec 2005
-$19.36M(-215.1%)
-$14.53M(-680.4%)
-$19.36M(-192.3%)
Sep 2005
-
-$1.86M(-23.3%)
-$6.62M(+5.4%)
Jun 2005
-
-$1.51M(-3.6%)
-$7.00M(-8.1%)
Mar 2005
-
-$1.46M(+18.7%)
-$6.48M(-5.5%)
Dec 2004
-$6.14M(-29.1%)
-$1.79M(+20.1%)
-$6.14M(-4.6%)
Sep 2004
-
-$2.24M(-127.2%)
-$5.87M(-3.6%)
Jun 2004
-
-$986.70K(+12.1%)
-$5.67M(-3.8%)
Mar 2004
-
-$1.12M(+26.2%)
-$5.46M(-14.7%)
Dec 2003
-$4.76M(-367.3%)
-$1.52M(+25.4%)
-$4.76M(-55.0%)
Sep 2003
-
-$2.04M(-162.4%)
-$3.07M(-89.6%)
Jun 2003
-
-$777.00K(-84.0%)
-$1.62M(-48.4%)
Mar 2003
-
-$422.20K(-350.9%)
-$1.09M(+16.0%)
Dec 2002
-$1.02M(+67.2%)
$168.30K(+128.6%)
-$1.30M(+35.9%)
Sep 2002
-
-$588.20K(-136.4%)
-$2.02M(+5.4%)
Jun 2002
-
-$248.80K(+60.5%)
-$2.14M(+36.4%)
Mar 2002
-
-$629.60K(-12.8%)
-$3.37M(-13.7%)
Dec 2001
-$3.11M(+1.7%)
-$558.20K(+20.8%)
-$2.96M(-3382.8%)
Sep 2001
-
-$704.50K(+52.2%)
-$85.00K(+75.3%)
Jun 2001
-
-$1.47M(-556.6%)
-$344.00K(+82.5%)
Mar 2001
-
-$224.40K(-109.7%)
-$1.97M(+37.4%)
Dec 2000
-$3.16M(-17.1%)
$2.32M(+340.5%)
-$3.15M(+48.1%)
Sep 2000
-
-$963.50K(+68.9%)
-$6.06M(-8.3%)
Jun 2000
-
-$3.10M(-120.8%)
-$5.60M(-74.9%)
Mar 2000
-
-$1.40M(-133.8%)
-$3.20M(-14.4%)
Dec 1999
-$2.70M(+15.6%)
-$600.00K(-20.0%)
-$2.80M(+22.2%)
Sep 1999
-
-$500.00K(+28.6%)
-$3.60M(+16.3%)
Jun 1999
-
-$700.00K(+30.0%)
-$4.30M(-53.6%)
Mar 1999
-
-$1.00M(+28.6%)
-$2.80M(+9.7%)
Dec 1998
-$3.20M(+39.6%)
-$1.40M(-16.7%)
-$3.10M(+6.1%)
Sep 1998
-
-$1.20M(-250.0%)
-$3.30M(-6.5%)
Jun 1998
-
$800.00K(+161.5%)
-$3.10M(+44.6%)
Mar 1998
-
-$1.30M(+18.8%)
-$5.60M(-9.8%)
Dec 1997
-$5.30M(-43.2%)
-$1.60M(-60.0%)
-$5.10M(-10.9%)
Sep 1997
-
-$1.00M(+41.2%)
-$4.60M(+2.1%)
Jun 1997
-
-$1.70M(-112.5%)
-$4.70M(-30.6%)
Mar 1997
-
-$800.00K(+27.3%)
-$3.60M(-33.3%)
Dec 1996
-$3.70M
-$1.10M(0.0%)
-$2.70M(-68.8%)
Sep 1996
-
-$1.10M(-83.3%)
-$1.60M(-220.0%)
Jun 1996
-
-$600.00K(-700.0%)
-$500.00K(-600.0%)
Mar 1996
-
$100.00K
$100.00K

FAQ

  • What is TG Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual EBIT year-on-year change?
  • What is TG Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is TG Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. TTM EBIT year-on-year change?

What is TG Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of TGTX is $49.62M

What is the all-time high annual EBIT for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual earnings before interest & taxes is $49.62M

What is TG Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, TGTX annual earnings before interest & taxes has changed by +$23.95M (+93.25%)

What is TG Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of TGTX is $37.64M

What is the all-time high quarterly EBIT for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $117.64M

What is TG Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, TGTX quarterly earnings before interest & taxes has changed by +$27.11M (+257.48%)

What is TG Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of TGTX is $97.47M

What is the all-time high TTM EBIT for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $108.19M

What is TG Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, TGTX TTM earnings before interest & taxes has changed by -$10.71M (-9.90%)
On this page